Shengchun Liu

21PUBLICATIONS
14CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersMedical bacteriologyBioinformatic methods development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Oct 05, 2025
ARL3 Enhances ERα Stability via USP10 Deubiquitination to Promote Endocrine Resistance and Drive Mitochondrial Metabolic Reprogramming in HR+ Breast Cancer.

Han Li, Yang Liu, Zehao Cai

|Oct 02, 2024
A Phase II Clinical Study on Apatinib Plus Vinorelbine in Refractory HER2-Negative Breast Cancer and its Metabolic Implications of Drug Resistance.

Jing Wu, Pan Deng, La Zou

|Jun 24, 2024
SMAD4 depletion contributes to endocrine resistance by integrating ER and ERBB signaling in HR + HER2- breast cancer.

Kang Li, Dan Shu, Han Li

|May 18, 2023
Characterization of starvation response-related genes for predicting prognosis in breast cancer.

Yuan Wang, Shun Gao, Yingkun Xu

|Mar 29, 2023
An Angiogenesis-Related lncRNA Signature Is Associated with Prognosis and Tumor Immune Microenvironment in Breast Cancer.

Shun Gao, Yuan Wang, Yingkun Xu

|Feb 25, 2023
Nomograms for Predicting Disease-Free Survival Based on Core Needle Biopsy and Surgical Specimens in Female Breast Cancer Patients with Non-Pathological Complete Response to Neoadjuvant Chemotherapy.

Ailin Lan, Han Li, Junru Chen

Pageof 4

Frequent Collaborators

5 joint publications

Yingkun Xu

3 joint publications

Zhenrong Tang

1 joint publications

Yang Peng

1 joint publications

Yannan Zhao